Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Treasury Shares (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Treasury Shares for 4 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 38.1% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 38.1% year-over-year, with the annual reading at $2.5 million for FY2025, 38.1% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.5 million at Day One Biopharmaceuticals, down from $2.8 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.0 million in Q2 2025, with the low at $93250.0 in Q3 2023.
  • Average Treasury Shares over 4 years is $1.5 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Treasury Shares crashed 78.59% in 2023, then surged 1923.86% in 2024.
  • Over 4 years, Treasury Shares stood at $485351.0 in 2022, then skyrocketed by 95.6% to $949370.0 in 2023, then soared by 86.89% to $1.8 million in 2024, then soared by 38.1% to $2.5 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.5 million, $2.8 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.